IL22 and psoriasis: In psoriasis, a benign inflammatory skin disease characterized by hyperproliferative keratinocytes, IL-22 induces inflammation, mediates keratinocyte proliferation, and inhibits keratinocyte terminal differentiation [16], [17], [18].